Alumni Ventures

Kalderos, Inc. is a healthcare technology company that specializes in drug discount management solutions. Founded in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and optimize the coordination of drug discount programs for healthcare providers, manufacturers, and payers. The platform employs advanced models and machine learning processes to identify and resolve non-compliance issues, detect inconsistencies, and provide data management capabilities. By offering features such as claims verification, dispute resolution, and discount monitoring, Kalderos enables its clients to streamline the communication and payment processes associated with drug discounts, ultimately eliminating waste and enhancing efficiency in the healthcare system.

Lumanu, Inc. is a digital marketing platform that connects brands with influencers and creators. Founded in 2016 and headquartered in Oakland, California, with an additional office in Milwaukee, Wisconsin, Lumanu offers a suite of solutions designed to facilitate collaboration in the creator economy. Its SocialCert product enables influencers to share content and usage rights with marketers, while Content Manager allows for the ingestion of influencer-generated content. Additionally, the SmartBoost solution assists in creating advertisements using creative assets from influencers. By providing tools for payment management, compliance, and content collaboration, Lumanu empowers creators and freelancers to effectively manage their businesses and foster meaningful partnerships with brand marketers, agency marketers, and performance marketers.

Asto CT LLC is a company focused on developing advanced X-ray computed tomography (CT) systems specifically for equine care. Founded in 2015 and based in Madison, Wisconsin, Asto CT aims to enhance the quality of life for horses while ensuring peace of mind for their owners. The company's innovative technology allows for rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, significantly improving fracture risk detection and enabling effective diagnosis of lameness and dental issues. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is at the forefront of improving diagnostic capabilities for conditions affecting horses, particularly in the distal limb and head and neck areas.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

Cultured Decadence is a cellular aquaculture startup based in Madison, Wisconsin, founded in 2020. The company specializes in innovative methods to produce crustacean products, specifically focusing on lobster and crab meat. Utilizing cell culture and tissue engineering techniques, Cultured Decadence creates seafood directly from the cells of these animals, eliminating the need for shells, organs, and waste. This approach aims to address the increasing global demand for nutritious and sustainable seafood, providing a more environmentally friendly alternative to traditional fishing practices.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

Asto CT LLC is a company focused on developing advanced X-ray computed tomography (CT) systems specifically for equine care. Founded in 2015 and based in Madison, Wisconsin, Asto CT aims to enhance the quality of life for horses while ensuring peace of mind for their owners. The company's innovative technology allows for rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, significantly improving fracture risk detection and enabling effective diagnosis of lameness and dental issues. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is at the forefront of improving diagnostic capabilities for conditions affecting horses, particularly in the distal limb and head and neck areas.

Somna Therapeutics LLC, founded in March 2012 in partnership with the Medical College of Wisconsin, is a medical device company based in Germantown, Wisconsin. The company specializes in developing solutions for laryngopharyngeal reflux (LPR) and extraesophageal acid reflux diseases (EERD). Its primary product, the Reza Band, is a non-pharmacologic, investigational device designed to prevent reflux into the larynx, pharynx, and lungs. This non-invasive device aims to improve the quality of life for individuals suffering from these conditions. Somna Therapeutics is currently focused on optimizing product design and completing clinical trials to obtain FDA clearance, with plans to market the Reza Band to hospitals, physician clinics, and home health care providers upon successful approval and launch.

HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, specializing in innovative search, analytics, and imaging solutions tailored for cancer care providers. Founded in 2013, the company aims to enhance clinical decision-making by offering real-time, evidence-based imaging insights that support optimized patient care and reduce delivery costs. HealthMyne's technology enables physicians to manipulate tumor images and access electronic health records and image repositories, facilitating the diagnosis and treatment of similar cases. The company’s platform also focuses on improving patient management through features such as automatic tumor staging, dose overlays, and specialized reporting, which streamline clinical workflows and support precision medicine initiatives.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.

HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, specializing in innovative search, analytics, and imaging solutions tailored for cancer care providers. Founded in 2013, the company aims to enhance clinical decision-making by offering real-time, evidence-based imaging insights that support optimized patient care and reduce delivery costs. HealthMyne's technology enables physicians to manipulate tumor images and access electronic health records and image repositories, facilitating the diagnosis and treatment of similar cases. The company’s platform also focuses on improving patient management through features such as automatic tumor staging, dose overlays, and specialized reporting, which streamline clinical workflows and support precision medicine initiatives.